Disc Medicine (IRON) Other Non Operating Income (2021 - 2026)
Disc Medicine (IRON) posted quarterly Other Non Operating Income of -$12000.0 for Q2 2026, down 117.65% year-over-year from $68000.0 in Q2 2025, and down 154.55% quarter-over-quarter from $22000.0 in Q1 2026.
Powered by 
Analysis
Disc Medicine (IRON) Other Non Operating Income (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Other Non Operating Income for 6 consecutive years, with -$12000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non Operating Income fell 117.65% year-over-year to -$12000.0; the TTM figure through Jun 2026 stood at $13.0 million (up 16749.35% YoY), while the FY2025 annual figure was $13.0 million, up 651550.0% from the prior year.
- Other Non Operating Income slipped to -$12000.0 in Q2 2026 per IRON's latest filing, from $22000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $13.0 million in Q4 2025 and bottomed at -$5.9 million in Q3 2022.
- Historically, Other Non Operating Income has averaged $763176.5 across 5 years, with a median of $3000.0 in 2024.
- On a YoY basis, Other Non Operating Income climbed as much as 432633.33% in 2025 and fell as far as 300.0% in 2025.
- Disc Medicine's Other Non Operating Income stood at $3.4 million in 2022, then sank by 100.3% to -$10000.0 in 2023, then jumped by 130.0% to $3000.0 in 2024, then jumped by 432633.33% to $13.0 million in 2025, then tumbled by 100.09% to -$12000.0 in 2026.
- Business Quant data shows IRON's Other Non Operating Income at -$12000.0 in Q2 2026, $22000.0 in Q1 2026, and $13.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 12.98 Mn |
| Sep 30, 2025 | -18,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | -5.94 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | -5.05 Mn |